SEC FORM 4CLUSTER · 2 INSIDERS
$1,671,990.00
RELMADA THERAPEUTICS, INC. (RLMD)
Purchase of 400,000 shares across 2 reporting persons.
Transaction Code P · Reporting Persons 2
- TRAVERSA SERGIO, Chief Executive OfficerPurchase of 100,000 shares at $4.18 per share.$418,000.00
- Shenouda Maged, Chief Financial OfficerPurchase of 120,200 shares at $4.20 per share.$504,840.00
- TRAVERSA SERGIO, Chief Executive OfficerPurchase of 100,000 shares at $4.1 per share.$410,000.00
- Shenouda Maged, Chief Financial OfficerPurchase of 79,800 shares at $4.25 per share.$339,150.00
Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.
Traded Sep 9, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001213900-26-098969 · filed 2026-09-11 · View filing →
Source: SEC Form 4 · 0001213900-26-098970 · filed 2026-09-11 · View filing →